Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Impact of Autophagy and Aging on Iron Load and Ferritin in Drosophila Brain.

Jacomin AC, Geraki K, Brooks J, Tjendana-Tjhin V, Collingwood JF, Nezis IP.

Front Cell Dev Biol. 2019 Jul 25;7:142. doi: 10.3389/fcell.2019.00142. eCollection 2019.

2.

Metal Ion Binding to the Amyloid β Monomer Studied by Native Top-Down FTICR Mass Spectrometry.

Lermyte F, Everett J, Lam YPY, Wootton CA, Brooks J, Barrow MP, Telling ND, Sadler PJ, O'Connor PB, Collingwood JF.

J Am Soc Mass Spectrom. 2019 Jul 26. doi: 10.1007/s13361-019-02283-7. [Epub ahead of print]

PMID:
31350722
3.

Synchrotron XRF imaging of Alzheimer's disease basal ganglia reveals linear dependence of high-field magnetic resonance microscopy on tissue iron concentration.

Finnegan ME, Visanji NP, Romero-Canelon I, House E, Rajan S, Mosselmans JFW, Hazrati LN, Dobson J, Collingwood JF.

J Neurosci Methods. 2019 May 1;319:28-39. doi: 10.1016/j.jneumeth.2019.03.002. Epub 2019 Mar 6.

4.

Metallome of cerebrovascular endothelial cells infected with Toxoplasma gondii using μ-XRF imaging and inductively coupled plasma mass spectrometry.

Al-Sandaqchi AT, Brignell C, Collingwood JF, Geraki K, Mirkes EM, Kong K, Castellanos M, May ST, Stevenson CW, Elsheikha HM.

Metallomics. 2018 Oct 17;10(10):1401-1414. doi: 10.1039/c8mt00136g.

PMID:
30183049
5.

The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease.

Aliakbari F, Mohammad-Beigi H, Rezaei-Ghaleh N, Becker S, Dehghani Esmatabad F, Eslampanah Seyedi HA, Bardania H, Tayaranian Marvian A, Collingwood JF, Christiansen G, Zweckstetter M, Otzen DE, Morshedi D.

Nanoscale. 2018 May 17;10(19):9174-9185. doi: 10.1039/c8nr00632f.

PMID:
29725687
6.

Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.

Everett J, Collingwood JF, Tjendana-Tjhin V, Brooks J, Lermyte F, Plascencia-Villa G, Hands-Portman I, Dobson J, Perry G, Telling ND.

Nanoscale. 2018 Jul 5;10(25):11782-11796. doi: 10.1039/c7nr06794a.

7.

Iron Biochemistry is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer's Disease.

Telling ND, Everett J, Collingwood JF, Dobson J, van der Laan G, Gallagher JJ, Wang J, Hitchcock AP.

Cell Chem Biol. 2017 Oct 19;24(10):1205-1215.e3. doi: 10.1016/j.chembiol.2017.07.014. Epub 2017 Sep 7.

8.

Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.

Heidari M, Johnstone DM, Bassett B, Graham RM, Chua AC, House MJ, Collingwood JF, Bettencourt C, Houlden H, Ryten M, Olynyk JK, Trinder D, Milward EA.

Mol Psychiatry. 2016 Nov;21(11):1599-1607. doi: 10.1038/mp.2015.192. Epub 2016 Jan 5.

9.

Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.

Heidari M, Gerami SH, Bassett B, Graham RM, Chua AC, Aryal R, House MJ, Collingwood JF, Bettencourt C, Houlden H, Ryten M; UK Brain Expression Consortium (UKBEC), Olynyk JK, Trinder D, Johnstone DM, Milward EA.

Rare Dis. 2016 Jun 22;4(1):e1198458. doi: 10.1080/21675511.2016.1198458. eCollection 2016.

10.

High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease.

Plascencia-Villa G, Ponce A, Collingwood JF, Arellano-Jiménez MJ, Zhu X, Rogers JT, Betancourt I, José-Yacamán M, Perry G.

Sci Rep. 2016 Apr 28;6:24873. doi: 10.1038/srep24873.

11.

Gene co-expression networks shed light into diseases of brain iron accumulation.

Bettencourt C, Forabosco P, Wiethoff S, Heidari M, Johnstone DM, Botía JA, Collingwood JF, Hardy J; UK Brain Expression Consortium (UKBEC), Milward EA, Ryten M, Houlden H.

Neurobiol Dis. 2016 Mar;87:59-68. doi: 10.1016/j.nbd.2015.12.004. Epub 2015 Dec 18.

12.

The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light.

Collingwood JF, Davidson MR.

Front Pharmacol. 2014 Aug 19;5:191. doi: 10.3389/fphar.2014.00191. eCollection 2014. Review.

13.

Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42).

Everett J, Céspedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA, Arenholz E, Telling ND.

J R Soc Interface. 2014 Mar 26;11(95):20140165. doi: 10.1098/rsif.2014.0165. Print 2014 Jun 6.

14.

Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide β-amyloid.

Everett J, Céspedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA, Arenholz E, Telling ND.

Inorg Chem. 2014 Mar 17;53(6):2803-9. doi: 10.1021/ic402406g. Epub 2014 Feb 21.

PMID:
24559299
15.

Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.

Visanji NP, Collingwood JF, Finnegan ME, Tandon A, House E, Hazrati LN.

J Parkinsons Dis. 2013;3(4):523-37. doi: 10.3233/JPD-130197.

PMID:
24113558
16.

Concentration of various trace elements in the rat retina and their distribution in different structures.

Ugarte M, Grime GW, Lord G, Geraki K, Collingwood JF, Finnegan ME, Farnfield H, Merchant M, Bailey MJ, Ward NI, Foster PJ, Bishop PN, Osborne NN.

Metallomics. 2012 Dec;4(12):1245-54. doi: 10.1039/c2mt20157g.

PMID:
23093062
17.

Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress.

Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, Lynch MA.

J Alzheimers Dis. 2012;28(1):147-61. doi: 10.3233/JAD-2011-110614.

PMID:
21971404
18.

High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron.

Antharam V, Collingwood JF, Bullivant JP, Davidson MR, Chandra S, Mikhaylova A, Finnegan ME, Batich C, Forder JR, Dobson J.

Neuroimage. 2012 Jan 16;59(2):1249-60. doi: 10.1016/j.neuroimage.2011.08.019. Epub 2011 Aug 16.

19.

Spherulites of amyloid-beta42 in vitro and in Alzheimer's disease.

Exley C, House E, Collingwood JF, Davidson MR, Cannon D, Donald AM.

J Alzheimers Dis. 2010;20(4):1159-65. doi: 10.3233/JAD-2010-091630.

20.

Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material.

Collingwood JF, Chong RK, Kasama T, Cervera-Gontard L, Dunin-Borkowski RE, Perry G, Pósfai M, Siedlak SL, Simpson ET, Smith MA, Dobson J.

J Alzheimers Dis. 2008 Jun;14(2):235-45.

PMID:
18560134
21.

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM.

Neurology. 2007 May 22;68(21):1820-5.

PMID:
17515544
22.

In situ characterization and mapping of iron compounds in Alzheimer's disease tissue.

Collingwood JF, Mikhaylova A, Davidson M, Batich C, Streit WJ, Terry J, Dobson J.

J Alzheimers Dis. 2005 Aug;7(4):267-72.

PMID:
16131727

Supplemental Content

Loading ...
Support Center